Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of atorvastatin on the nitric oxide system in patients with non-diabetic nephropathy
2010-019202-17Phase 2Completed
- Sponsor
- Medicinsk Forskning
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of atorvastatin in chronic kidney disease (CKD) and Non-diabetic nephropathy, sponsored by Medicinsk Forskning. Primary endpoints: Primary endpoint: effect of atorvastatin on L-NMMA-induced changes in renal tubular transport, Primary endpoint: effect on central hemodynamics and 1 more. Started Apr 2010; status: completed.
02
Drugs
atorvastatin
03
Conditions
chronic kidney disease (CKD)Non-diabetic nephropathy
Beyond the preview
Go deeper on 2010-019202-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019202-17.